United Therapeutics CorpNASDAQ:UTHR
- LAST PRICE357.7200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots355.2800/ 1
- Ask / Lots361.0000/ 2
- Open / Previous Close--- / 357.7200
- Day Range---
- 52 Week Range
- Volume1
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UTHR |
|---|---|---|
| 09:32 ET | 3947 | 359.995 |
| 09:34 ET | 172 | 359.06 |
| 09:45 ET | 200 | 360.82 |
| 09:48 ET | 299 | 361.71 |
| 09:50 ET | 200 | 361.99 |
| 09:52 ET | 100 | 361.9899 |
| 09:54 ET | 400 | 361.18 |
| 09:56 ET | 1638 | 361.71 |
| 09:57 ET | 100 | 361.055 |
| 09:59 ET | 700 | 360.815 |
| 10:01 ET | 700 | 361.74 |
| 10:06 ET | 200 | 362.24 |
| 10:08 ET | 600 | 362.23 |
| 10:12 ET | 100 | 362.52 |
| 10:15 ET | 132 | 362.275 |
| 10:24 ET | 100 | 362.295 |
| 10:26 ET | 2603 | 361.47 |
| 10:28 ET | 100 | 361.335 |
| 10:30 ET | 100 | 361.23 |
| 10:33 ET | 200 | 360.79 |
| 10:35 ET | 601 | 360.98 |
| 10:37 ET | 400 | 362 |
| 10:46 ET | 1761 | 361.805 |
| 10:51 ET | 100 | 361.46 |
| 10:53 ET | 100 | 361.04 |
| 10:57 ET | 200 | 360.93 |
| 11:04 ET | 325 | 361.28 |
| 11:06 ET | 100 | 360.8 |
| 11:09 ET | 230 | 361.04 |
| 11:11 ET | 200 | 360.6 |
| 11:13 ET | 541 | 360.42 |
| 11:18 ET | 200 | 360.46 |
| 11:22 ET | 600 | 360.555 |
| 11:26 ET | 300 | 361.27 |
| 11:27 ET | 283 | 361.55 |
| 11:31 ET | 100 | 362.27 |
| 11:36 ET | 300 | 362.46 |
| 11:38 ET | 500 | 362.46 |
| 11:40 ET | 1375 | 361.965 |
| 11:51 ET | 100 | 361.8 |
| 11:56 ET | 400 | 362.27 |
| 12:02 ET | 100 | 362.075 |
| 12:05 ET | 3491 | 360.69 |
| 12:12 ET | 650 | 361.3999 |
| 12:16 ET | 100 | 361 |
| 12:18 ET | 125 | 360.99 |
| 12:20 ET | 646 | 361.3 |
| 12:23 ET | 353 | 360.74 |
| 12:25 ET | 741 | 361.05 |
| 12:27 ET | 200 | 360.79 |
| 12:32 ET | 400 | 360.155 |
| 12:34 ET | 202 | 360.1692 |
| 12:36 ET | 100 | 360.03 |
| 12:38 ET | 100 | 360 |
| 12:39 ET | 291 | 359.84 |
| 12:41 ET | 200 | 359.86 |
| 12:43 ET | 200 | 359.76 |
| 12:45 ET | 200 | 359.89 |
| 12:50 ET | 439 | 359.78 |
| 12:52 ET | 100 | 359.63 |
| 12:56 ET | 100 | 359.45 |
| 12:57 ET | 100 | 359.68 |
| 12:59 ET | 100 | 359.45 |
| 01:01 ET | 602 | 358.84 |
| 01:03 ET | 1000 | 359.27 |
| 01:08 ET | 100 | 359.485 |
| 01:12 ET | 100 | 359.24 |
| 01:15 ET | 100 | 358.65 |
| 01:17 ET | 100 | 358.685 |
| 01:19 ET | 100 | 358.65 |
| 01:21 ET | 741 | 358.44 |
| 01:24 ET | 1100 | 358.625 |
| 01:28 ET | 600 | 358.68 |
| 01:30 ET | 700 | 358.64 |
| 01:33 ET | 1145 | 358.555 |
| 01:35 ET | 200 | 358.555 |
| 01:37 ET | 700 | 358.65 |
| 01:39 ET | 200 | 358.785 |
| 01:42 ET | 1400 | 358.25 |
| 01:44 ET | 100 | 358.24 |
| 01:48 ET | 604 | 357.63 |
| 01:50 ET | 463 | 357.63 |
| 01:53 ET | 100 | 357.47 |
| 01:57 ET | 100 | 357.745 |
| 02:02 ET | 100 | 357.74 |
| 02:04 ET | 1400 | 357.335 |
| 02:06 ET | 111 | 357.245 |
| 02:08 ET | 276 | 357.59 |
| 02:09 ET | 100 | 357.485 |
| 02:11 ET | 200 | 357.46 |
| 02:13 ET | 600 | 357.78 |
| 02:15 ET | 100 | 357.735 |
| 02:18 ET | 100 | 357.75 |
| 02:22 ET | 200 | 357.5 |
| 02:24 ET | 1107 | 358.37 |
| 02:26 ET | 500 | 358.55 |
| 02:27 ET | 300 | 358.55 |
| 02:29 ET | 401 | 358.435 |
| 02:31 ET | 400 | 357.75 |
| 02:33 ET | 100 | 357.61 |
| 02:36 ET | 100 | 357.43 |
| 02:38 ET | 200 | 357.51 |
| 02:40 ET | 100 | 357.825 |
| 02:42 ET | 200 | 357.5 |
| 02:45 ET | 100 | 357.43 |
| 02:47 ET | 100 | 357.3985 |
| 02:49 ET | 200 | 357.38 |
| 02:54 ET | 100 | 357.22 |
| 02:56 ET | 100 | 357.14 |
| 02:58 ET | 700 | 357.38 |
| 03:00 ET | 100 | 357.38 |
| 03:02 ET | 400 | 357.31 |
| 03:05 ET | 2923 | 357.71 |
| 03:07 ET | 200 | 357.58 |
| 03:09 ET | 100 | 357.49 |
| 03:14 ET | 685 | 357.15 |
| 03:16 ET | 400 | 357.14 |
| 03:18 ET | 200 | 357.01 |
| 03:21 ET | 1200 | 357.5 |
| 03:23 ET | 100 | 357.41 |
| 03:25 ET | 100 | 357.39 |
| 03:27 ET | 600 | 357.79 |
| 03:30 ET | 200 | 357.55 |
| 03:32 ET | 500 | 357.54 |
| 03:34 ET | 901 | 357.095 |
| 03:36 ET | 200 | 357.27 |
| 03:38 ET | 500 | 357.125 |
| 03:39 ET | 1400 | 357.385 |
| 03:41 ET | 992 | 357.38 |
| 03:43 ET | 589 | 357.39 |
| 03:45 ET | 2111 | 357.55 |
| 03:48 ET | 1559 | 357.5 |
| 03:50 ET | 1367 | 357.68 |
| 03:52 ET | 346 | 357.42 |
| 03:54 ET | 1852 | 358.01 |
| 03:56 ET | 1613 | 357.79 |
| 03:57 ET | 2100 | 357.73 |
| 03:59 ET | 73639 | 357.72 |
Sep 24, 2024
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting, from 7:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
7:00AM ET on Tuesday Sep 24, 2024 by Dow Jones
Sep 23, 2024
DJ United Therapeutics Is Maintained at Buy by Jefferies, from 11:30AM ET on Monday Sep 23, 2024 by Dow Jones
11:30AM ET on Monday Sep 23, 2024 by Dow Jones
Sep 16, 2024
DJ Liquidia Says U.S. Court Found United Therapeutics Caused Losses of More Than $137M, from 10:34AM ET on Monday Sep 16, 2024 by Dow Jones
10:34AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 10, 2024
Aug 28, 2024
DJ United Therapeutics Is Maintained at Outperform by Oppenheimer, from 9:08AM ET on Wednesday Aug 28, 2024 by Dow Jones
9:08AM ET on Wednesday Aug 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United Therapeutics Corp | 15.9B | 16.4x | +8.22% |
Biomarin Pharmaceutical Inc | 13.4B | 53.0x | --- |
Exact Sciences Corp | 12.6B | -70.7x | --- |
Neurocrine Biosciences Inc | 11.7B | 35.0x | +62.04% |
Qiagen NV | 10.1B | 141.5x | +12.66% |
Beigene Ltd | 23.3B | -41.9x | --- |
Company Information
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Contact Information
- Headquarters
- 1000 SPRING STSILVER SPRING, MD, United States 20910
- Phone
- 301-608-9292
- Fax
- 301-608-9291
Executives
- Chairman of the Board, Chief Executive Officer
- Martine Rothblatt
- President, Chief Operating Officer
- Michael Benkowitz
- Lead Independent Vice Chairman of the Board
- Christopher Patusky
- Chief Financial Officer, Treasurer
- James Edgemond
- Executive Vice President, General Counsel, Corporate Secretary
- Paul Mahon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $15.9B |
|---|---|
Revenue (TTM) | $2.6B |
Shares Outstanding | 44.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.57 |
EPS | $21.75 |
Book Value | $127.23 |
P/E Ratio | 16.4x |
Price/Sales (TTM) | 6.1 |
Price/Cash Flow (TTM) | 14.1x |
Operating Margin | 48.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
